Liquid Cardiac Control

The Acusera Smart Liquid Cardiac Control is designed to cover a range of cardiac markers at clinical decision levels, eliminating the need for additional low-level controls at extra expenses. It is intended for use with in vitrodiagnostic assays for the quantitative determination of 7 cardiac markers, for use in the routine monitoring of both accuracy and precision. This control also has an impressive 14 day open vial stability for Troponin I, and 30 days for other analytes.

Features & Benefits

• Liquid frozen requiring minimal preparation.
• Human serum based providing a matrix similar to the patient sample.
• Open vial stability of 30 days at 2-8ºC for most analytes (excluding Troponin I).
• Consolidates 7 key cardiac markers.
• Cut off levels for Troponin I in line with internationally recommended levels.

Acusera Smartscan (Siemens Atellica)

Acusera Smartload

Analytes

• CK-MB
• Homocysteine
• hsCRP
• Myoglobin
• Troponin I
• Digoxin
• NT-proBNP